Home|Journals|Articles by Year|Audio Abstracts

Review Article

Elastase and COVID-19 relationship, and potential natural resource as elastase inhibitors: A comprehensive review

Neneng Siti Silfi Ambarwati, Yesi Desmiaty, Islamudin Ahmad, Erwin Samsul, Adam M. Ramadhan.


SARS-Cov-2 is the culprit behind the acute respiratory syndrome COVID-19. Immunopathological mechanisms that cause excessive inflammation and neutrophil activation cause this syndrome. Neutrophils are crucial for the removal of viruses and other infectious agents. This study aims to comprehensively examine the relationship between elastase enzymes and COVID-19, as well as natural resources as elastase inhibitors. The literature was searched using electronic databases such as Directory Open-Access Journal, Google Scholar, National Health Institute, PubMed, ScienceDirect, and Web of Science between October 2021 and August 2022. This narrative review article highlights some aspects of the relationship between elastase and COVID-19, including the general pathophysiology of COVID-19, protease enzymes and protease inhibitors, neutrophil extracellular traps (NET), NET cell death, elastin and desmosine, elastase and antielastase, elastase and thrombin, elastase and angiotensin-converting enzyme 2 (ACE2), elastase and cathepsin C, correlation of elastase and COVID-19, COVID-19 therapy, and natural products resource as elastase inhibitors.

Key words: COVID-19, elastase inhibition, natural products, neutrophil elastase

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.